Results

Total Results: 1,274 records

Showing results for "weight".
Users also searched for: obesity screening

141. Diabetes Type 2 | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/diabetes-type-2?page=0
     May 08, 2018 - symptoms can include Being very thirsty Urinating often Feeling very hungry or tired Losing weight … Effectiveness Review Systematic Review Archived March 25, 2013 Strategies To Prevent Weight

142. A Comparative Effectiveness Study of Intensive Glycemic Control vs. Less Intensive Control in Type 2 Diabetes | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/glycemic-control/abstract
     December 01, 2019 - with basal insulin), are of particular interest as these medications are associated with harms such as weight … Outcomes to be measured include weight gain, hypoglycemic episodes, cardiovascular endpoints, onset of

143. Automated-Entry Patient-Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/health-data-mapping/report
     June 01, 2021 - consistent evidence of a lack of effect of PGHD interventions on the surrogate outcome of body mass index/weight … For obesity, we rated the health outcomes as unclear, and the surrogate outcomes (body mass index/weight … Student volunteers involved in device usability testing of the Weight Watchers Online app found it well-designed

144. Utilization and Clinical Data on In-Hospital Off-Label Uses of Recombinant Factor VIIa | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/recombinant-factor-viia/clinician
     March 01, 2020 - effect of treating spontaneous intracranial hemorrhage with rFVIIa at doses ≤40 μg/kg of patient body weight … Increased risk for arterial thromboembolic events , particularly at doses >40 μg/kg of patient body weight … effect of treating spontaneous intracranial hemorrhage with rFVIIa at doses ≤40 μg/kg of patient body weight

145. Obesity Prevention and Control (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/obesity-research-methods_research-protocol.pdf
     February 08, 2017 - outcome used in the meta- analysis.17 As demonstrated in the review,16 few studies included BMI or weight … To address the limitations of the evidence base, this review will include both BMI and weight outcomes … , as well as the more proximal, weight related behavioral outcomes. … Body weight ii. BMI iii. Individual dietary behavior iv. Individual physical activity behavior v. … outcomes: Weight and BMI; obesity-related dietary or physical activity behavioral outcomes).

146. Omega-3-Maternity Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/omega-3-maternity_research-protocol.pdf
     May 18, 2015 - for preterm birth, intrauterine growth retardation (IUGR) (small-for-gestational age and low birth weight … ); birth weight, length, and head circumference; neurological development; visual function in the first … Question (KQ) 1(Maternal exposures and outcomes) § Healthy pregnant women (for outcomes of birth weight … • Mean birth weight • Incidence of low birth weight/small for gestational age o Pediatric Outcomes … OR weight)) OR newborn OR neonatal OR (grow* AND (child* OR infant* OR infancy)) OR "Retinopathy of

147. Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/effect-dietary-digestible/research
     March 01, 2025 - The evidence was insufficient to determine an association between carbohydrate intake and weight or body … conducted, one addressing cardiovascular outcomes and the second addressing incidence of T2D, body weight … The evidence was insufficient to determine an association between carbohydrate intake and weight or body

148. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_disposition-comments.pdf
     August 12, 2016 - As the reviewer notes, we excluded weight loss studies. … We would have captured weight changes subgroup analyses, if reported. … change since weight change could relate to many of the outcomes being examined. … Weight change was not an outcome of interest. Weight loss intervention studies were excluded. … Weight change was not reported in eligible studies that we saw.

149. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
     February 01, 2008 - pharmacologic agent within the defined classes (oral antiplatelet agents, injectable low molecular weight … Classes include oral antiplatelet agents, injectable low molecular weight heparins (LMWH), injectable … heparin versus low-molecular weight heparin plus compression stockings versus compression stockings … UFH.mp 46. heparin, low-molecular weight/ 47. low molecular weight heparin.mp 48. … UFH.mp 28. heparin, low-molecular weight/ 29. low molecular weight heparin.mp 30.

150. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
     February 01, 2008 - pharmacologic agent within the defined classes (oral antiplatelet agents, injectable low molecular weight … Classes include oral antiplatelet agents, injectable low molecular weight heparins (LMWH), injectable … heparin versus low-molecular weight heparin plus compression stockings versus compression stockings … UFH.mp 46. heparin, low-molecular weight/ 47. low molecular weight heparin.mp 48. … UFH.mp 28. heparin, low-molecular weight/ 29. low molecular weight heparin.mp 30.

151. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
     January 01, 2015 - This is particularly the case with the weight key points (p20-1). … Weight effect summary: TZD and SU associated with weight gain, DPP4 inhibitors with weight maintenance … , and GLP1 agonists and SGLT2 inhibitors with weight loss. … insulin with weight gain? … We have added that insulin is associated with weight gain.

152. Who Uses Exenatide For Glucose Control in Diabetes Mellitus? A Retrospective Cohort Study of a New Therapy | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/diabetes-glucose-control/research
     January 01, 2020 - non-inferiority relative to insulin glargine 10 and insulin aspart. 11 These trials also demonstrated weight … of individuals with obesity was highest in the group prescribed exenatide, an anticipated finding as weight … The known side-effect of weight loss could have motivated use of this medication, although we cannot … Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated … Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients

153. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label_executive.pdf
     January 01, 2007 - Olanzapine caused significant weight gain in all studies. … In two pooled RCTs of dementia patients, olanzapine users were 6.12 times more likely to report weight … gain of 1.0, 0.7, and 0.4 pounds while on treatment, compared to a weight loss among placebo-treated … Even greater weight gain relative to placebo has been reported in trials of non-elderly adults. … Mean weight gain in the risperidone groups ranged from 2.1 kg to 3.9 kg per study.

154. Diabetes Type 2 | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/diabetes-type-2?page=1
     July 10, 2012 - symptoms can include Being very thirsty Urinating often Feeling very hungry or tired Losing weight … Research Protocol Archived October 25, 2011 Comparative Effectiveness of Approaches to Weight

155. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar-2010_research-protocol.pdf
     January 01, 2010 - maintain normoglycemia without inducing significant hypoglycemia, and to maintain normal/ideal body weight … risk for severer hypoglycemic episodes. 10 Finally, intensive insulin therapy can also lead to weight … There was a statistically significant increase in mean birth weight associated with CSII when compared … Weight gain d. Hypoglycemia frequency 3. Clinical outcomes a. … Weight gain associated with intensive therapy in the diabetes control and complications trial.

156. Topic Brief: Antenatal Care (pdf file)
     effectivehealthcare-admin.ahrq.gov/system/files/docs/topic-brief-antenatal-care.pdf
     April 01, 2021 - stress and anxiety Fetal/neonatal outcomes: Mortality; morbidity (e.g. pre-term birth, low birth weight … stress and anxiety Fetal/neonatal outcomes: Mortality; morbidity (e.g. pre-term birth, low birth weight … various approaches to telehealth-delivered antenatal care, including remote patient monitoring of weight … Effect of Lifestyle Coaching Including Telemonitoring and Telecoaching on Gestational Weight Gain and … Postnatal Weight Loss: A Systematic Review.

157. CER 215 Executive Summary: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
     March 01, 2019 - Seizures • Serious adverse events • Suicide/suicide attempt • Suicidal thoughts • SIADH/hyponatremia • Weight … cognitive function, falls, fracture, mortality, seizures, serious AEs, hyponatremia, suicide/ attempt, weight … fractures, mortality, serious ADEAE, seizures, sodium/hyponatremia, suicidal thoughts, suicide/ attempt, weight … SSRI 2 RCTs10,20 Any AE, blood pressure, falls, fractures, mortality, serious AE, weight, withdrawal … SSRI 1 RCT22 Any AE, blood pressure, hospitalization, serious AE, weight, withdrawal due to AE Trazodone

158. Dia 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/ijzerman_ahrq-webinar-mcda.pdf
     January 01, 2011 - Dia 1 1 Integrating stakeholder preferences in comparative effectiveness research using multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA) Maarten J. IJzerman, PhD Professor and chair, department Health Technology & Services Research m.j.ijzerman@utwente.nl Multiple endpoints in …

159. Comparative Effectiveness and Safety of Oral Diabetes Medications for Adults With Type 2 Diabetes: An Update of the 2007 Report | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/type-2-diabetes-medications-update/research-protocol
     December 01, 2019 - morbidity and mortality. 1-3 Management of type 2 diabetes is complex and involves recommendations for weight … 2 for lists of comparisons) for the intermediate outcomes of glycemic control (in terms of HgbA1c), weight … Intermediate outcomes are glycemic control, serum lipid levels, weight, and blood pressure. … Intermediate outcomes are glycemic control, serum lipid levels, weight, and blood pressure. … For Key Question 1, we included the following outcomes: HgbA1c, weight, and serum lipid levels (HDL,

160. Meditation Programs for Stress and Well-Being | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/meditation/research-protocol
     December 01, 2019 - of meditative programs on affect, attention, health-related behaviors affected by stress, pain, and weight … and negative affect, attention, well-being, health-related behaviors affected by stress, pain, and weight … Question 4: What are the efficacy and harms of meditation programs on pain and weight among those with … However, since weight is affected by multiple inputs including eating, weight will be evaluated as its … (body mass index and weight loss) Harms (any noted by the study such as exacerbation of psychosis